Select Publications
Journal articles
, 2018, 'Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry', American Journal of Kidney Diseases, 71, pp. 814 - 821, http://dx.doi.org/10.1053/j.ajkd.2017.10.017
, 2018, 'FP468RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', Nephrology Dialysis Transplantation, 33, pp. i194 - i194, http://dx.doi.org/10.1093/ndt/gfy104.fp468
, 2018, 'The relationship between body mass index and organism-specific peritonitis', Peritoneal Dialysis International, 38, pp. 206 - 214, http://dx.doi.org/10.3747/pdi.2017.00188
, 2018, 'Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)', BMJ Open, 8, pp. e018794, http://dx.doi.org/10.1136/bmjopen-2017-018794
, 2017, 'Outcomes of corynebacterium peritonitis: A multicenter registry analysis', Peritoneal Dialysis International, 37, pp. 619 - 626, http://dx.doi.org/10.3747/pdi.2017.00028
, 2017, 'Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 22, pp. 823 - 824, http://dx.doi.org/10.1111/nep.12823
, 2017, 'Breast Cancer and Transplantation', American Journal of Transplantation, 17, pp. 2243 - 2253, http://dx.doi.org/10.1111/ajt.14368
, 2017, 'Representativeness of honeypot trial participants to Australasian PD patients', Peritoneal Dialysis International, 37, pp. 516 - 522, http://dx.doi.org/10.3747/pdi.2016.00065
, 2017, 'TEMPORAL TRENDS IN CLINICAL OUTCOMES OF KIDNEY TRANSPLANTATION FROM 1996 TO 2013 IN AUSTRALIA AND NEW ZEALAND', NEPHROLOGY, 22, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408833200309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis', Clinical Journal of the American Society of Nephrology, 12, pp. 1090 - 1099, http://dx.doi.org/10.2215/CJN.12321216
, 2017, 'Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial', Nephrology, 22, pp. 548 - 554, http://dx.doi.org/10.1111/nep.12815
, 2017, 'EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', NEPHROLOGY DIALYSIS TRANSPLANTATION, 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469797101230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'SP427GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS', Nephrology Dialysis Transplantation, 32, pp. iii264 - iii265, http://dx.doi.org/10.1093/ndt/gfx149.sp427
, 2017, 'SP493EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', Nephrology Dialysis Transplantation, 32, pp. iii294 - iii294, http://dx.doi.org/10.1093/ndt/gfx151.sp493
, 2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial', Nieren Und Hochdruckkrankheiten, 46, pp. 172 - 173
, 2017, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2017, http://dx.doi.org/10.1002/14651858.CD009966.pub2
, 2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis a randomized clinical trial', JAMA Internal Medicine, 177, pp. 184 - 193, http://dx.doi.org/10.1001/jamainternmed.2016.8029
, 2017, 'Association of socio-economic position with technique failure and mortality in australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, 37, pp. 397 - 406, http://dx.doi.org/10.3747/pdi.2016.00209
, 2017, 'Carvedilol and cardiac biomarkers in dialysis patients: Secondary analysis of a randomized controlled trial', Kidney and Blood Pressure Research, 42, pp. 1033 - 1044, http://dx.doi.org/10.1159/000485589
, 2017, 'Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - A population cohort study', Oncotarget, 8, pp. 77771 - 77782, http://dx.doi.org/10.18632/oncotarget.20781
, 2016, 'Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: Proposal for a standardized definition of technique failure', Peritoneal Dialysis International, 36, pp. 623 - 630, http://dx.doi.org/10.3747/pdi.2015.00218
, 2016, 'Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients', Clinical Journal of the American Society of Nephrology, 11, pp. 1845 - 1855, http://dx.doi.org/10.2215/CJN.00190116
, 2016, 'The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, 68, pp. 554 - 563, http://dx.doi.org/10.1053/j.ajkd.2016.03.418
, 2016, 'Center-specific factors associated with peritonitis risk—a multi-center registry analysis', Peritoneal Dialysis International, 36, pp. 509 - 518, http://dx.doi.org/10.3747/pdi.2015.00146
, 2016, 'Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials', Nephrology Dialysis Transplantation, 31, pp. 1425 - 1436, http://dx.doi.org/10.1093/ndt/gfv269
, 2016, 'Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis', JAMA Journal of the American Medical Association, 316, pp. 313 - 324, http://dx.doi.org/10.1001/jama.2016.9400
, 2016, 'Appetite predicts intake and nutritional status in patients receiving peritoneal dialysis', Journal of Renal Care, 42, pp. 123 - 131, http://dx.doi.org/10.1111/jorc.12156
, 2016, 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial', American Journal of Kidney Diseases, 67, pp. 902 - 911, http://dx.doi.org/10.1053/j.ajkd.2015.10.029
, 2016, 'Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study', Nephrology, 21, pp. 387 - 396, http://dx.doi.org/10.1111/nep.12629
, 2016, 'Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 21, pp. 217 - 228, http://dx.doi.org/10.1111/nep.12573
, 2016, 'The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial', Redox Report, 21, pp. 14 - 23, http://dx.doi.org/10.1179/1351000215Y.0000000022
, 2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ Online, 355, http://dx.doi.org/10.1136/bmj.i5599
, 2016, 'Long-term outcomes of end-stage kidney disease for patients with lupus nephritis', Kidney International, 89, pp. 1337 - 1345, http://dx.doi.org/10.1016/j.kint.2016.02.014
, 2016, 'MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', Nephrology Dialysis Transplantation, 31, pp. i413 - i413, http://dx.doi.org/10.1093/ndt/gfw187.27
, 2015, 'The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: A sub-study of the Honeypot trial', Peritoneal Dialysis International, 35, pp. 712 - 721, http://dx.doi.org/10.3747/pdi.2014.00206
, 2015, 'End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy-Outcomes in 66 consecutive ANZDATA registry cases', American Journal of Nephrology, 42, pp. 177 - 184, http://dx.doi.org/10.1159/000440815
, 2015, 'DISPARITIES IN SURVIVAL OF DIALYSIS PATIENTS IN AUSTRALIA BASED UPON ETHNICITY AND COUNTRY OF BIRTH', NEPHROLOGY, 20, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AND CLINICAL OUTCOMES IN ADULT KIDNEY TRANSPLANT RECIPIENTS', NEPHROLOGY, 20, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial', Canadian Journal of Kidney Health and Disease, 2, http://dx.doi.org/10.1186/s40697-015-0066-5
, 2015, 'Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, 35, pp. 450 - 459, http://dx.doi.org/10.3747/pdi.2013.00004
, 2015, 'The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: The updated final trial protocol and rationale of post-initiation trial modifications', BMC Nephrology, 16, http://dx.doi.org/10.1186/s12882-015-0089-2
, 2015, 'A nephrology guide to reading and using systematic reviews of randomized trials', Nephrology Dialysis Transplantation, 30, pp. 878 - 884, http://dx.doi.org/10.1093/ndt/gfu222
, 2015, 'The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study', Nephrology, 20, pp. 140 - 147, http://dx.doi.org/10.1111/nep.12362
, 2015, 'The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 35, pp. 222 - 228, http://dx.doi.org/10.3747/pdi.2013.00156
, 2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial', American Journal of Kidney Diseases, 65, pp. 49 - 57, http://dx.doi.org/10.1053/j.ajkd.2014.06.020
, 2015, 'Daily home hemodialysis: Balancing cardiovascular benefits with infectious harms', American Journal of Kidney Diseases, 65, pp. 6 - 8, http://dx.doi.org/10.1053/j.ajkd.2014.08.012
, 2015, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews
, 2014, 'The association between body mass index and mortality in incident dialysis patients', Plos One, 9, http://dx.doi.org/10.1371/journal.pone.0114897
, 2014, 'End-stage kidney disease due to alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases', Nephrology Dialysis Transplantation, 29, pp. 2277 - 2286, http://dx.doi.org/10.1093/ndt/gfu254
, 2014, 'Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis', Nephrology Dialysis Transplantation, 29, pp. 1940 - 1947, http://dx.doi.org/10.1093/ndt/gfu050